期刊
CHEMICAL SCIENCE
卷 7, 期 3, 页码 1645-1652出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c5sc04229a
关键词
-
资金
- BBSRC
- GE Healthcare
- Royal Society
Positron emission tomography (PET) is becoming more frequently used by medicinal chemists to facilitate the selection of the most promising lead compounds for further evaluation. For PET, this entails the preparation of C-11- or F-18-labeled drugs or radioligands. With the importance of chirality and fluorine substitution in drug development, chemists can be faced with the challenge of preparing enantiopure molecules featuring the F-18-tag on a stereogenic carbon. Asymmetric F-18-fluorination is an emerging field of research that provides an alternative to resolution or conventional S(N)2-based radiochemistry. To date, both transition metal complexes and organomediators have been successfully employed for F-18-incorporation at a stereogenic carbon.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据